But it is useful for patients who present with obvious upper respiratory tract infections. If someone is clearly sick the test will work.
The availability of antibody tests such as this one enables other (direct virus) tests to be prioritised to specific patient cohorts .
The overall level of testing can therefore be increased because antibody tests are available.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
AN1
anagenics limited
Add to My Watchlist
0.00%
!
0.8¢

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-145
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.970M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable